Gliomas are the most common tumours of the central nervous system and the most
aggressive form is glioblastoma (GBM). Despite advances in treatment, patient survival …

Circulating Tumor Cells (CTCs) are cancer cells that split away from the primary tumor and
appear in the circulatory system as singular units or clusters, which was first reported by Dr …

More recently, disease metastasis and relapse in many cancer patients several years (even
some decades) after surgical remission are regarded as tumor dormancy. However, the …

Tumor biopsy is the gold standard for the assessment of clinical biomarkers for treatment.
However, tumors change dynamically in response to therapy, and there remains a need for …

Head and neck cancer is the sixth most common cancer worldwide. It remains one of the
leading causes of death, and its early detection is crucial. Liquid biopsy has emerged as a …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most commonly diagnosed
cancer worldwide. Despite advances in the treatment management, locally advanced …

Lung cancer is the leading cause of cancer morbidity and mortality worldwide and early
diagnosis is crucial for the management and treatment of this disease. Non-invasive means …

Circulating tumour cells (CTCs) are the metastatic precursors to distant disease in head and
neck cancers (HNCs). Whilst the prognostic and predictive value of single CTCs have been …

Whilst locoregional control of head and neck cancers (HNCs) has improved over the last
four decades, long-term survival has remained largely unchanged. A possible reason for this …

Head and neck squamous cell carcinoma (HNSCC) represents a heterogeneous group of
tumors. While significant progress has been made using multimodal treatment, the 5‐year …